Next-Generation Synthetic Biology Workflow Platform

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, October 2022
Volume 46
Issue 10
Pages: 12

Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.

Codex DNA’s BioXp 9600 System

Codex DNA’s BioXp 9600 System

Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences. Designed for use with synthetic biology workflows, the system provides overnight, automated synthesis of genes, clones, DNA libraries, and mRNA. It is capable of processing up to 96 gene fragments overnight.

The system features a unique instrument design that is intended to minimize benchtop footprint while also increasing throughput and versatility. Proprietary error correction and Gibson assembly technology automate the identification and removal of mismatches introduced during synthesis and assembly.

Codex DNA

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content